Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Warrants Presented at Fair Value (Tables)

v3.21.1
Warrants Presented at Fair Value (Tables)
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of outstanding warrants classified as a liability
Outstanding     Exercise price   Issuance year   Exercisable through   Fair value      
                         
  120,000     $ 0.92(*)   2014   (*****)     6     (********)
  296,813       1.50   2015   2020     -     (********)
  374,001       1.50   2016   2021     2     (********)
  905,555       0.17   2017   2022     22,027     Refer to Note 8b
  333,333       1.50   2017   2022     96     Refer to Note 11b5
  53,333       1.50   2017   2022     2     Refer to Note 11b1
  50,000       1.50   2017   2022     3     Refer to Note 8a
  33,332       1.20   2017   2022     16     Refer to Note 8b
  33,332       1.00   2017   2022     16     Refer to Note 8b
  675,926        (**)   2017   2022     68,275     Refer to Note 3
  11,111       1.20   2017   2022     4     Refer to Note 11b7
  300,000       0.50   2018   2023     1,560     Refer to Note 11b6
  1,659,971       0.17   2018   2022     11,522     Refer to Note 8b
  29,411,765       0.17(***)   2018   2021(******)     420,386     Refer to Note 8e
  15,441,177        (****)    (****)   (****)     220,704     Refer to Note 8e
  6,617,647       0.17(***)   2018   2020(*******)     50,510     Refer to Note 8f
  11,764,706       0.17(***)   2018   2020(*******)     107,602     Refer to Note 8g
  1,411,765       0.17(***)   2019   2024   $ 49,100     Refer to Note 8g
  5,882,352       0.17(***)   2019   2021(*******)     61,541     Refer to Note 8h
  18,382,352       0.17(***)   2019   2021(******)     262,742     Refer to Note 8e
  13,970,587     $ 0.17(***)   2019   2021(*******)     227,998     Refer to Note 8i
                             
  107,729,058                 $ 1,504,112     (*********)
(*) Subject to changes as describe in the agreement.
(**) Less than $0.01.
(***) Subject to a mechanism described in the agreement but not less than $0.17, therefore, the outstanding amounts were calculated based on an exercise price of $0.17, which results in the maximum potential amount of warrants.
(****) Since the actual number of warrants cannot be determined as of December 31, 2019, the outstanding amounts were calculated based on an exercise price of $0.17, which results in the maximum potential amount of warrants.
(*****) M&A or qualified PO as described in the agreement.
(******) Two years from the registration statement or a PO, the earlier
(*******) Two years or a PO, the earlier.
(********) Issued in connection with the 2016, 2015 and 2014 financing rounds.
(*********)  Contains warrants presented at fair value within current liabilities of $158,112 and within non-current liabilities of $1,346,000.